Edition:
India

Amgen Reports Qtrly GAAP Earnings Per Share $3.05


Wednesday, 29 Jul 2020 

July 28 (Reuters) - Amgen Inc ::‍​QTRLY GAAP EARNINGS PER SHARE $3.05; QTRLY NON-GAAP EARNINGS PER SHARE $4.25; QTRLY TOTAL REVENUES UP 6% TO $6.21 BILLION.Q2 EARNINGS PER SHARE VIEW $3.82, REVENUE VIEW $6.19 BILLION -- REFINITIV IBES DATA.‍​2020 TOTAL REVENUE GUIDANCE REAFFIRMED AT $25.0 BILLION-$25.6 BILLION; SEES 2020 CAPEX TO BE ABOUT $600 MILLION.‍​2020 GAAP EPS GUIDANCE REVISED TO $10.73- $11.43; 2020 NON-GAAP EPS GUIDANCE REVISED TO $15.10-$15.75.FY2020 EARNINGS PER SHARE VIEW $15.64, REVENUE VIEW $25.43 BILLION -- REFINITIV IBES DATA.‍​GENERATED $2.7 BILLION OF FREE CASH FLOW IN Q2 VERSUS $1.3 BILLION.‍​NOTWITHSTANDING EFFECTS OF PANDEMIC, TOTAL PRODUCT SALES UP 6% FOR Q2.Q2 ‍​PRODUCT SALES UP DRIVEN BY 13% VOLUME GROWTH ACROSS NEWER PRODUCTS, INCLUDING OTEZLA, MVASI, KANJINTI, EVENITY, REPATHA.‍​SALES OF NEGATIVELY-AFFECTED PRODUCTS FELL MOST EARLY IN Q2 WITH SALES BEGINNING TO RECOVER IN LATTER WEEKS OF Q2.